开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=590346, encodeId=137659034649, content=审稿速度:1.0 经验分享：投了一个图片版块的。没什么临床价值就是个稀奇的案例，先投NEJM被拒后投的他们，很快收了，见刊等了半年。发个案评职称没什么用，纯属兴趣爱好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c901619173, createdName=squidbear, createdTime=Wed May 06 21:06:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198931, encodeId=34751198931a4, content=偏重的研究方向：急救 经验分享：2021年3月投稿一篇千把字的case，历时1年，编辑拒绝但给个机会说找润色再投，三个审稿人大修小修，每轮修回都给了4个月，编辑又说让我把稿子发给他私人帮忙修改一点，2022年1月刚刚接受，2022年2月给proof，现在还没发表。很严谨很折腾很考验临床思维的几回合，所幸遇到了很好的编辑，非常感激。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=162341520, createdName=kaysang, createdTime=Thu Mar 03 07:36:02 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086691, encodeId=aa7c108669106, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086692, encodeId=c5f11086692f1, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574438, encodeId=24a35e44382c, content=您投的是个案报道吗liweixbin 2018-11-03 00:00:00 发表: 您好，可以发给我看看好吗。想投一下。 liweixbin@163.com 如果可以分享，多谢了, beContent=liweixbin 2018-11-03 00:00:00 发表: 您好，可以发给我看看好吗。想投一下。 liweixbin@163.com 如果可以分享，多谢了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0942243910, createdName=1214d8c2m38暂无昵称, createdTime=Mon Aug 05 00:00:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562704, encodeId=3109562e04ef, content=您好，可以发给我看看好吗。想投一下。 liweixbin@163.com 如果可以分享，多谢了 2018-10-11 00:00:00 发表: 投了 N个病例，终于中了一篇，看运气, beContent= 2018-10-11 00:00:00 发表: 投了 N个病例，终于中了一篇，看运气, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26c21483333, createdName=liweixbin, createdTime=Sat Nov 03 00:00:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847797, encodeId=af3784e7973f, content=投稿命中率:25.0 经验分享：这几年分数略有下降，不过并不影响，总的来说仍然是同领域内的顶级期刊. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae65413999, createdName=ms4600315023772712, createdTime=Mon Oct 22 09:51:21 CST 2018, time=2018-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561897, encodeId=3b1656189ea2, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投了 N个病例，终于中了一篇，看运气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2d01807974, createdName=ms7543807642109513, createdTime=Thu Oct 11 00:00:00 CST 2018, time=2018-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545107, encodeId=669e54510e66, content=心血管急症不错的投稿方向~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a7891590, createdName=popale, createdTime=Fri Aug 04 10:40:00 CST 2017, time=2017-08-04, status=1, ipAttribution=)]

2020-05-06 squidbear

审稿速度:1.0
经验分享：投了一个图片版块的。没什么临床价值就是个稀奇的案例，先投NEJM被拒后投的他们，很快收了，见刊等了半年。发个案评职称没什么用，纯属兴趣爱好。

3 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=590346, encodeId=137659034649, content=审稿速度:1.0 经验分享：投了一个图片版块的。没什么临床价值就是个稀奇的案例，先投NEJM被拒后投的他们，很快收了，见刊等了半年。发个案评职称没什么用，纯属兴趣爱好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c901619173, createdName=squidbear, createdTime=Wed May 06 21:06:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198931, encodeId=34751198931a4, content=偏重的研究方向：急救 经验分享：2021年3月投稿一篇千把字的case，历时1年，编辑拒绝但给个机会说找润色再投，三个审稿人大修小修，每轮修回都给了4个月，编辑又说让我把稿子发给他私人帮忙修改一点，2022年1月刚刚接受，2022年2月给proof，现在还没发表。很严谨很折腾很考验临床思维的几回合，所幸遇到了很好的编辑，非常感激。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=162341520, createdName=kaysang, createdTime=Thu Mar 03 07:36:02 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086691, encodeId=aa7c108669106, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086692, encodeId=c5f11086692f1, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574438, encodeId=24a35e44382c, content=您投的是个案报道吗liweixbin 2018-11-03 00:00:00 发表: 您好，可以发给我看看好吗。想投一下。 liweixbin@163.com 如果可以分享，多谢了, beContent=liweixbin 2018-11-03 00:00:00 发表: 您好，可以发给我看看好吗。想投一下。 liweixbin@163.com 如果可以分享，多谢了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0942243910, createdName=1214d8c2m38暂无昵称, createdTime=Mon Aug 05 00:00:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562704, encodeId=3109562e04ef, content=您好，可以发给我看看好吗。想投一下。 liweixbin@163.com 如果可以分享，多谢了 2018-10-11 00:00:00 发表: 投了 N个病例，终于中了一篇，看运气, beContent= 2018-10-11 00:00:00 发表: 投了 N个病例，终于中了一篇，看运气, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26c21483333, createdName=liweixbin, createdTime=Sat Nov 03 00:00:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847797, encodeId=af3784e7973f, content=投稿命中率:25.0 经验分享：这几年分数略有下降，不过并不影响，总的来说仍然是同领域内的顶级期刊. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae65413999, createdName=ms4600315023772712, createdTime=Mon Oct 22 09:51:21 CST 2018, time=2018-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561897, encodeId=3b1656189ea2, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投了 N个病例，终于中了一篇，看运气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2d01807974, createdName=ms7543807642109513, createdTime=Thu Oct 11 00:00:00 CST 2018, time=2018-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545107, encodeId=669e54510e66, content=心血管急症不错的投稿方向~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a7891590, createdName=popale, createdTime=Fri Aug 04 10:40:00 CST 2017, time=2017-08-04, status=1, ipAttribution=)]

2022-03-03 kaysang

偏重的研究方向：急救
经验分享：2021年3月投稿一篇千把字的case，历时1年，编辑拒绝但给个机会说找润色再投，三个审稿人大修小修，每轮修回都给了4个月，编辑又说让我把稿子发给他私人帮忙修改一点，2022年1月刚刚接受，2022年2月给proof，现在还没发表。很严谨很折腾很考验临床思维的几回合，所幸遇到了很好的编辑，非常感激。

83 0

[GetPortalCommentsPageByObjectIdResponse(id=590346, encodeId=137659034649, content=审稿速度:1.0 经验分享：投了一个图片版块的。没什么临床价值就是个稀奇的案例，先投NEJM被拒后投的他们，很快收了，见刊等了半年。发个案评职称没什么用，纯属兴趣爱好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c901619173, createdName=squidbear, createdTime=Wed May 06 21:06:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198931, encodeId=34751198931a4, content=偏重的研究方向：急救 经验分享：2021年3月投稿一篇千把字的case，历时1年，编辑拒绝但给个机会说找润色再投，三个审稿人大修小修，每轮修回都给了4个月，编辑又说让我把稿子发给他私人帮忙修改一点，2022年1月刚刚接受，2022年2月给proof，现在还没发表。很严谨很折腾很考验临床思维的几回合，所幸遇到了很好的编辑，非常感激。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=162341520, createdName=kaysang, createdTime=Thu Mar 03 07:36:02 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086691, encodeId=aa7c108669106, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086692, encodeId=c5f11086692f1, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574438, encodeId=24a35e44382c, content=您投的是个案报道吗liweixbin 2018-11-03 00:00:00 发表: 您好，可以发给我看看好吗。想投一下。 liweixbin@163.com 如果可以分享，多谢了, beContent=liweixbin 2018-11-03 00:00:00 发表: 您好，可以发给我看看好吗。想投一下。 liweixbin@163.com 如果可以分享，多谢了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0942243910, createdName=1214d8c2m38暂无昵称, createdTime=Mon Aug 05 00:00:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562704, encodeId=3109562e04ef, content=您好，可以发给我看看好吗。想投一下。 liweixbin@163.com 如果可以分享，多谢了 2018-10-11 00:00:00 发表: 投了 N个病例，终于中了一篇，看运气, beContent= 2018-10-11 00:00:00 发表: 投了 N个病例，终于中了一篇，看运气, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26c21483333, createdName=liweixbin, createdTime=Sat Nov 03 00:00:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847797, encodeId=af3784e7973f, content=投稿命中率:25.0 经验分享：这几年分数略有下降，不过并不影响，总的来说仍然是同领域内的顶级期刊. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae65413999, createdName=ms4600315023772712, createdTime=Mon Oct 22 09:51:21 CST 2018, time=2018-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561897, encodeId=3b1656189ea2, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投了 N个病例，终于中了一篇，看运气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2d01807974, createdName=ms7543807642109513, createdTime=Thu Oct 11 00:00:00 CST 2018, time=2018-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545107, encodeId=669e54510e66, content=心血管急症不错的投稿方向~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a7891590, createdName=popale, createdTime=Fri Aug 04 10:40:00 CST 2017, time=2017-08-04, status=1, ipAttribution=)]

2021-12-29 乌云背后的幸福线

讨论中局限性怎么撰写？

91 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=590346, encodeId=137659034649, content=审稿速度:1.0 经验分享：投了一个图片版块的。没什么临床价值就是个稀奇的案例，先投NEJM被拒后投的他们，很快收了，见刊等了半年。发个案评职称没什么用，纯属兴趣爱好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c901619173, createdName=squidbear, createdTime=Wed May 06 21:06:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198931, encodeId=34751198931a4, content=偏重的研究方向：急救 经验分享：2021年3月投稿一篇千把字的case，历时1年，编辑拒绝但给个机会说找润色再投，三个审稿人大修小修，每轮修回都给了4个月，编辑又说让我把稿子发给他私人帮忙修改一点，2022年1月刚刚接受，2022年2月给proof，现在还没发表。很严谨很折腾很考验临床思维的几回合，所幸遇到了很好的编辑，非常感激。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=162341520, createdName=kaysang, createdTime=Thu Mar 03 07:36:02 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086691, encodeId=aa7c108669106, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086692, encodeId=c5f11086692f1, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574438, encodeId=24a35e44382c, content=您投的是个案报道吗liweixbin 2018-11-03 00:00:00 发表: 您好，可以发给我看看好吗。想投一下。 liweixbin@163.com 如果可以分享，多谢了, beContent=liweixbin 2018-11-03 00:00:00 发表: 您好，可以发给我看看好吗。想投一下。 liweixbin@163.com 如果可以分享，多谢了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0942243910, createdName=1214d8c2m38暂无昵称, createdTime=Mon Aug 05 00:00:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562704, encodeId=3109562e04ef, content=您好，可以发给我看看好吗。想投一下。 liweixbin@163.com 如果可以分享，多谢了 2018-10-11 00:00:00 发表: 投了 N个病例，终于中了一篇，看运气, beContent= 2018-10-11 00:00:00 发表: 投了 N个病例，终于中了一篇，看运气, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26c21483333, createdName=liweixbin, createdTime=Sat Nov 03 00:00:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847797, encodeId=af3784e7973f, content=投稿命中率:25.0 经验分享：这几年分数略有下降，不过并不影响，总的来说仍然是同领域内的顶级期刊. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae65413999, createdName=ms4600315023772712, createdTime=Mon Oct 22 09:51:21 CST 2018, time=2018-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561897, encodeId=3b1656189ea2, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投了 N个病例，终于中了一篇，看运气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2d01807974, createdName=ms7543807642109513, createdTime=Thu Oct 11 00:00:00 CST 2018, time=2018-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545107, encodeId=669e54510e66, content=心血管急症不错的投稿方向~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a7891590, createdName=popale, createdTime=Fri Aug 04 10:40:00 CST 2017, time=2017-08-04, status=1, ipAttribution=)]

2021-12-29 学医的彭于晏

讨论中一般可以讨论什么？

81 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=590346, encodeId=137659034649, content=审稿速度:1.0 经验分享：投了一个图片版块的。没什么临床价值就是个稀奇的案例，先投NEJM被拒后投的他们，很快收了，见刊等了半年。发个案评职称没什么用，纯属兴趣爱好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c901619173, createdName=squidbear, createdTime=Wed May 06 21:06:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198931, encodeId=34751198931a4, content=偏重的研究方向：急救 经验分享：2021年3月投稿一篇千把字的case，历时1年，编辑拒绝但给个机会说找润色再投，三个审稿人大修小修，每轮修回都给了4个月，编辑又说让我把稿子发给他私人帮忙修改一点，2022年1月刚刚接受，2022年2月给proof，现在还没发表。很严谨很折腾很考验临床思维的几回合，所幸遇到了很好的编辑，非常感激。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=162341520, createdName=kaysang, createdTime=Thu Mar 03 07:36:02 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086691, encodeId=aa7c108669106, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086692, encodeId=c5f11086692f1, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574438, encodeId=24a35e44382c, content=您投的是个案报道吗liweixbin 2018-11-03 00:00:00 发表: 您好，可以发给我看看好吗。想投一下。 liweixbin@163.com 如果可以分享，多谢了, beContent=liweixbin 2018-11-03 00:00:00 发表: 您好，可以发给我看看好吗。想投一下。 liweixbin@163.com 如果可以分享，多谢了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0942243910, createdName=1214d8c2m38暂无昵称, createdTime=Mon Aug 05 00:00:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562704, encodeId=3109562e04ef, content=您好，可以发给我看看好吗。想投一下。 liweixbin@163.com 如果可以分享，多谢了 2018-10-11 00:00:00 发表: 投了 N个病例，终于中了一篇，看运气, beContent= 2018-10-11 00:00:00 发表: 投了 N个病例，终于中了一篇，看运气, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26c21483333, createdName=liweixbin, createdTime=Sat Nov 03 00:00:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847797, encodeId=af3784e7973f, content=投稿命中率:25.0 经验分享：这几年分数略有下降，不过并不影响，总的来说仍然是同领域内的顶级期刊. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae65413999, createdName=ms4600315023772712, createdTime=Mon Oct 22 09:51:21 CST 2018, time=2018-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561897, encodeId=3b1656189ea2, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投了 N个病例，终于中了一篇，看运气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2d01807974, createdName=ms7543807642109513, createdTime=Thu Oct 11 00:00:00 CST 2018, time=2018-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545107, encodeId=669e54510e66, content=心血管急症不错的投稿方向~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a7891590, createdName=popale, createdTime=Fri Aug 04 10:40:00 CST 2017, time=2017-08-04, status=1, ipAttribution=)]

2019-08-05 1214d8c2m38暂无昵称

您投的是个案报道吗liweixbin 2018-11-03 00:00:00 发表:
您好，可以发给我看看好吗。想投一下。 liweixbin@163.com 如果可以分享，多谢了

liweixbin 2018-11-03 00:00:00 发表: 您好，可以发给我看看好吗。想投一下。 liweixbin@163.com 如果可以分享，多谢了

221 0

[GetPortalCommentsPageByObjectIdResponse(id=590346, encodeId=137659034649, content=审稿速度:1.0 经验分享：投了一个图片版块的。没什么临床价值就是个稀奇的案例，先投NEJM被拒后投的他们，很快收了，见刊等了半年。发个案评职称没什么用，纯属兴趣爱好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c901619173, createdName=squidbear, createdTime=Wed May 06 21:06:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198931, encodeId=34751198931a4, content=偏重的研究方向：急救 经验分享：2021年3月投稿一篇千把字的case，历时1年，编辑拒绝但给个机会说找润色再投，三个审稿人大修小修，每轮修回都给了4个月，编辑又说让我把稿子发给他私人帮忙修改一点，2022年1月刚刚接受，2022年2月给proof，现在还没发表。很严谨很折腾很考验临床思维的几回合，所幸遇到了很好的编辑，非常感激。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=162341520, createdName=kaysang, createdTime=Thu Mar 03 07:36:02 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086691, encodeId=aa7c108669106, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086692, encodeId=c5f11086692f1, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574438, encodeId=24a35e44382c, content=您投的是个案报道吗liweixbin 2018-11-03 00:00:00 发表: 您好，可以发给我看看好吗。想投一下。 liweixbin@163.com 如果可以分享，多谢了, beContent=liweixbin 2018-11-03 00:00:00 发表: 您好，可以发给我看看好吗。想投一下。 liweixbin@163.com 如果可以分享，多谢了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0942243910, createdName=1214d8c2m38暂无昵称, createdTime=Mon Aug 05 00:00:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562704, encodeId=3109562e04ef, content=您好，可以发给我看看好吗。想投一下。 liweixbin@163.com 如果可以分享，多谢了 2018-10-11 00:00:00 发表: 投了 N个病例，终于中了一篇，看运气, beContent= 2018-10-11 00:00:00 发表: 投了 N个病例，终于中了一篇，看运气, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26c21483333, createdName=liweixbin, createdTime=Sat Nov 03 00:00:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847797, encodeId=af3784e7973f, content=投稿命中率:25.0 经验分享：这几年分数略有下降，不过并不影响，总的来说仍然是同领域内的顶级期刊. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae65413999, createdName=ms4600315023772712, createdTime=Mon Oct 22 09:51:21 CST 2018, time=2018-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561897, encodeId=3b1656189ea2, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投了 N个病例，终于中了一篇，看运气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2d01807974, createdName=ms7543807642109513, createdTime=Thu Oct 11 00:00:00 CST 2018, time=2018-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545107, encodeId=669e54510e66, content=心血管急症不错的投稿方向~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a7891590, createdName=popale, createdTime=Fri Aug 04 10:40:00 CST 2017, time=2017-08-04, status=1, ipAttribution=)]

2018-11-03 liweixbin

您好，可以发给我看看好吗。想投一下。 liweixbin@163.com 如果可以分享，多谢了 2018-10-11 00:00:00 发表:
投了 N个病例，终于中了一篇，看运气

2018-10-11 00:00:00 发表: 投了 N个病例，终于中了一篇，看运气

248 0

[GetPortalCommentsPageByObjectIdResponse(id=590346, encodeId=137659034649, content=审稿速度:1.0 经验分享：投了一个图片版块的。没什么临床价值就是个稀奇的案例，先投NEJM被拒后投的他们，很快收了，见刊等了半年。发个案评职称没什么用，纯属兴趣爱好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c901619173, createdName=squidbear, createdTime=Wed May 06 21:06:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198931, encodeId=34751198931a4, content=偏重的研究方向：急救 经验分享：2021年3月投稿一篇千把字的case，历时1年，编辑拒绝但给个机会说找润色再投，三个审稿人大修小修，每轮修回都给了4个月，编辑又说让我把稿子发给他私人帮忙修改一点，2022年1月刚刚接受，2022年2月给proof，现在还没发表。很严谨很折腾很考验临床思维的几回合，所幸遇到了很好的编辑，非常感激。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=162341520, createdName=kaysang, createdTime=Thu Mar 03 07:36:02 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086691, encodeId=aa7c108669106, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086692, encodeId=c5f11086692f1, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574438, encodeId=24a35e44382c, content=您投的是个案报道吗liweixbin 2018-11-03 00:00:00 发表: 您好，可以发给我看看好吗。想投一下。 liweixbin@163.com 如果可以分享，多谢了, beContent=liweixbin 2018-11-03 00:00:00 发表: 您好，可以发给我看看好吗。想投一下。 liweixbin@163.com 如果可以分享，多谢了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0942243910, createdName=1214d8c2m38暂无昵称, createdTime=Mon Aug 05 00:00:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562704, encodeId=3109562e04ef, content=您好，可以发给我看看好吗。想投一下。 liweixbin@163.com 如果可以分享，多谢了 2018-10-11 00:00:00 发表: 投了 N个病例，终于中了一篇，看运气, beContent= 2018-10-11 00:00:00 发表: 投了 N个病例，终于中了一篇，看运气, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26c21483333, createdName=liweixbin, createdTime=Sat Nov 03 00:00:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847797, encodeId=af3784e7973f, content=投稿命中率:25.0 经验分享：这几年分数略有下降，不过并不影响，总的来说仍然是同领域内的顶级期刊. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae65413999, createdName=ms4600315023772712, createdTime=Mon Oct 22 09:51:21 CST 2018, time=2018-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561897, encodeId=3b1656189ea2, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投了 N个病例，终于中了一篇，看运气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2d01807974, createdName=ms7543807642109513, createdTime=Thu Oct 11 00:00:00 CST 2018, time=2018-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545107, encodeId=669e54510e66, content=心血管急症不错的投稿方向~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a7891590, createdName=popale, createdTime=Fri Aug 04 10:40:00 CST 2017, time=2017-08-04, status=1, ipAttribution=)]

2018-10-22 ms4600315023772712

投稿命中率:25.0
经验分享：这几年分数略有下降，不过并不影响，总的来说仍然是同领域内的顶级期刊.

172 0

[GetPortalCommentsPageByObjectIdResponse(id=590346, encodeId=137659034649, content=审稿速度:1.0 经验分享：投了一个图片版块的。没什么临床价值就是个稀奇的案例，先投NEJM被拒后投的他们，很快收了，见刊等了半年。发个案评职称没什么用，纯属兴趣爱好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c901619173, createdName=squidbear, createdTime=Wed May 06 21:06:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198931, encodeId=34751198931a4, content=偏重的研究方向：急救 经验分享：2021年3月投稿一篇千把字的case，历时1年，编辑拒绝但给个机会说找润色再投，三个审稿人大修小修，每轮修回都给了4个月，编辑又说让我把稿子发给他私人帮忙修改一点，2022年1月刚刚接受，2022年2月给proof，现在还没发表。很严谨很折腾很考验临床思维的几回合，所幸遇到了很好的编辑，非常感激。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=162341520, createdName=kaysang, createdTime=Thu Mar 03 07:36:02 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086691, encodeId=aa7c108669106, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086692, encodeId=c5f11086692f1, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574438, encodeId=24a35e44382c, content=您投的是个案报道吗liweixbin 2018-11-03 00:00:00 发表: 您好，可以发给我看看好吗。想投一下。 liweixbin@163.com 如果可以分享，多谢了, beContent=liweixbin 2018-11-03 00:00:00 发表: 您好，可以发给我看看好吗。想投一下。 liweixbin@163.com 如果可以分享，多谢了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0942243910, createdName=1214d8c2m38暂无昵称, createdTime=Mon Aug 05 00:00:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562704, encodeId=3109562e04ef, content=您好，可以发给我看看好吗。想投一下。 liweixbin@163.com 如果可以分享，多谢了 2018-10-11 00:00:00 发表: 投了 N个病例，终于中了一篇，看运气, beContent= 2018-10-11 00:00:00 发表: 投了 N个病例，终于中了一篇，看运气, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26c21483333, createdName=liweixbin, createdTime=Sat Nov 03 00:00:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847797, encodeId=af3784e7973f, content=投稿命中率:25.0 经验分享：这几年分数略有下降，不过并不影响，总的来说仍然是同领域内的顶级期刊. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae65413999, createdName=ms4600315023772712, createdTime=Mon Oct 22 09:51:21 CST 2018, time=2018-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561897, encodeId=3b1656189ea2, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投了 N个病例，终于中了一篇，看运气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2d01807974, createdName=ms7543807642109513, createdTime=Thu Oct 11 00:00:00 CST 2018, time=2018-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545107, encodeId=669e54510e66, content=心血管急症不错的投稿方向~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a7891590, createdName=popale, createdTime=Fri Aug 04 10:40:00 CST 2017, time=2017-08-04, status=1, ipAttribution=)]

2018-10-11 ms7543807642109513

审稿速度:2.0 | 投稿命中率:25.0
经验分享：投了 N个病例，终于中了一篇，看运气

235 0

[GetPortalCommentsPageByObjectIdResponse(id=590346, encodeId=137659034649, content=审稿速度:1.0 经验分享：投了一个图片版块的。没什么临床价值就是个稀奇的案例，先投NEJM被拒后投的他们，很快收了，见刊等了半年。发个案评职称没什么用，纯属兴趣爱好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c901619173, createdName=squidbear, createdTime=Wed May 06 21:06:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198931, encodeId=34751198931a4, content=偏重的研究方向：急救 经验分享：2021年3月投稿一篇千把字的case，历时1年，编辑拒绝但给个机会说找润色再投，三个审稿人大修小修，每轮修回都给了4个月，编辑又说让我把稿子发给他私人帮忙修改一点，2022年1月刚刚接受，2022年2月给proof，现在还没发表。很严谨很折腾很考验临床思维的几回合，所幸遇到了很好的编辑，非常感激。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=162341520, createdName=kaysang, createdTime=Thu Mar 03 07:36:02 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086691, encodeId=aa7c108669106, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086692, encodeId=c5f11086692f1, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574438, encodeId=24a35e44382c, content=您投的是个案报道吗liweixbin 2018-11-03 00:00:00 发表: 您好，可以发给我看看好吗。想投一下。 liweixbin@163.com 如果可以分享，多谢了, beContent=liweixbin 2018-11-03 00:00:00 发表: 您好，可以发给我看看好吗。想投一下。 liweixbin@163.com 如果可以分享，多谢了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0942243910, createdName=1214d8c2m38暂无昵称, createdTime=Mon Aug 05 00:00:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562704, encodeId=3109562e04ef, content=您好，可以发给我看看好吗。想投一下。 liweixbin@163.com 如果可以分享，多谢了 2018-10-11 00:00:00 发表: 投了 N个病例，终于中了一篇，看运气, beContent= 2018-10-11 00:00:00 发表: 投了 N个病例，终于中了一篇，看运气, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26c21483333, createdName=liweixbin, createdTime=Sat Nov 03 00:00:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847797, encodeId=af3784e7973f, content=投稿命中率:25.0 经验分享：这几年分数略有下降，不过并不影响，总的来说仍然是同领域内的顶级期刊. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae65413999, createdName=ms4600315023772712, createdTime=Mon Oct 22 09:51:21 CST 2018, time=2018-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561897, encodeId=3b1656189ea2, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投了 N个病例，终于中了一篇，看运气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2d01807974, createdName=ms7543807642109513, createdTime=Thu Oct 11 00:00:00 CST 2018, time=2018-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545107, encodeId=669e54510e66, content=心血管急症不错的投稿方向~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a7891590, createdName=popale, createdTime=Fri Aug 04 10:40:00 CST 2017, time=2017-08-04, status=1, ipAttribution=)]

2017-08-04 popale

心血管急症不错的投稿方向~

357 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务